Immunochemically, the ERα (estrogen receptor α)-positive breast cancer, the most common breast cancer subtype, can be distinguished from Her2 (human epidermal receptor 2)-positive and triple negative breast cancers (negative for ERα, Her2 and progesterone receptor). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.